Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/1996
09/03/1996US5552300 T cell antigen receptor V region proteins and methods of preparation thereof
09/03/1996US5552152 Controlled release tablet
09/03/1996US5552150 Compostions containing di-linoleoyl-mono-gamma-linolenyl-glycerol
09/03/1996CA2169804A1 Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
09/03/1996CA1338572C Amino acid esters, process for the preparation thereof and use thereof
08/1996
08/29/1996WO1996026196A2 Benzylpiperidines and piperazines as muscarinic antagonists
08/29/1996WO1996026183A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
08/29/1996WO1996025948A1 PREPARATION AND USE OF A SPECIFIC GABA-Aα5 RECEPTOR LIGAND FOR TREATMENT OF ALZHEIMER'S DISEASE
08/29/1996WO1996025935A1 Method of treating adenosine depletion
08/29/1996WO1996025931A2 Use of fused benzothiazoles as neuroprotectants
08/29/1996WO1996025925A1 Nasal and ocular administration of ketamine to manage pain and for detoxification
08/29/1996CA2212525A1 Use of fused benzothiazoles as neuroprotectants
08/29/1996CA2170480A1 Methods of inhibiting estrogen positive tumors of the brain or cns
08/28/1996EP0728759A1 Heterocyclic compounds
08/28/1996EP0728738A1 Tetralinyl- and indanyl-ethylamides having melatonergic activity
08/28/1996EP0728209A1 Endothelin-converting enzyme
08/28/1996EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728138A1 Anthracycline derivatives
08/28/1996EP0728136A1 N-substituted azabicycloalkane derivatives, their preparation and use
08/28/1996EP0728129A1 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0728009A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
08/28/1996EP0728005A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
08/28/1996EP0727994A1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
08/28/1996EP0727986A1 Treatment of migraine
08/28/1996EP0678026B1 Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes
08/28/1996CN1129947A Polymeric matrices and their uses in pharmaceutical compositions
08/28/1996CN1129943A Vasoconstrictive substituted dihydropyranopyridines
08/28/1996CN1129942A Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity
08/28/1996CN1129939A Pharmacologically active enantiomers
08/28/1996CN1129938A Alkoxy-substituted beta-carbolines acting on the ampa-receptor
08/28/1996CN1129937A Indoline derivatives as 5HT2C antagonists
08/28/1996CN1129935A Vasoconstrictive substituted aryloxyalkyl diamines
08/28/1996CN1129933A 5-arylindole derivatives
08/28/1996CN1129905A Iontophoretic delivery of an antimigraine drug
08/28/1996CN1129702A Imidazopyridines
08/27/1996USRE35321 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity
08/27/1996US5550254 Reacting carboxylic acid with carbonyldiimidazole or thiocarbonyldiimidazole, adding phenol or thiophenol compound
08/27/1996US5550253 Reacting phenol or thiophenol derivative with lower alkyl p-toluenesulfonate, optionally reducing nitro groups to amino groups and acylating or alkylating them
08/27/1996US5550240 For inhibiting lipid peroxidation after brain or spinal column injuries
08/27/1996US5550239 Reacting trialkylsilyl n-pentylpiperazinylpyrimidine derivative with 4-amino-3-iodo-benzenesulfonamide compound in palladium catalyzed heteroannulation step, removing trialkylsilyl group with mineral acid, basifying
08/27/1996US5550162 N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydro-naphthalene-2-carboxamide derivatives, their preparation and their therapeutic use
08/27/1996US5550150 Using a benzothiophene compound
08/27/1996US5550145 Bactericides or fungicides as preservatives for cosmetics
08/27/1996US5550143 Heterocyclic compounds
08/27/1996US5550142 Phenyl heterocycles as cox-2 inhibitors
08/27/1996US5550136 Methanoanthrancenyl piperidyl antipsychotics
08/27/1996US5550130 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl)piperidines and related compounds and their therapeutic utility
08/27/1996US5550129 Benzopyranones, processes for their preparation and their use
08/27/1996US5550126 Psychological disorders, drug withdrawal
08/27/1996US5550125 Brain disorders
08/27/1996US5550124 Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996US5549912 Controlled release oxycodone compositions
08/27/1996US5549906 Nicotine lozenge and therapeutic method for smoking cessation
08/27/1996CA1338556C 4-substituted imidazole derivatives useful in perioperative care
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE
08/22/1996WO1996025414A1 Imidazo[1,2-a]pyridines for the treatment of cns and cardiac diseases
08/22/1996WO1996025411A1 Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025403A1 α-SUBSTITUTED HYDRAZIDES HAVING CALPAIN INHIBITORY ACTIVITY
08/22/1996WO1996025397A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996WO1996025387A1 Alkylcarboxy amino acids-modulators of the kainate receptor
08/22/1996WO1996025160A1 The use of heterocyclic compounds
08/22/1996WO1996025154A1 Transdermal formulation
08/22/1996CA2216648A1 Alkylcarboxy amino acids-modulators of the kainate receptor
08/22/1996CA2212874A1 Transdermal formulation
08/22/1996CA2211836A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996CA2208073A1 Alpha-substituted hydrazides having calpain inhibitory activity
08/21/1996EP0727421A1 Agents for improving sleep
08/21/1996EP0727215A2 Central cholecystokinin antagonists for treatment of psychiatric disorders
08/21/1996EP0727214A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
08/21/1996EP0727213A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
08/21/1996EP0727212A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
08/21/1996EP0727210A2 Analgesic agent and its use
08/21/1996EP0727208A1 Transdermal formulation of a compound having muscarinic activity
08/21/1996EP0726948A1 Method of inducing and maintaining neuronal cells
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726898A1 Phenylindole compounds
08/21/1996EP0726896A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726706A1 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists
08/21/1996EP0540614B1 3-(1-substitutedpyrazoyl)-2-oxindole derivatives
08/21/1996EP0516691B1 Neuropeptide control of ocular growth
08/21/1996EP0474672B1 New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129442A Benzodiazepine compounds useful as antagonisis of cck or of gastrine
08/21/1996CN1129441A Vitamin D analogues
08/21/1996CN1129399A The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
08/21/1996CN1129219A Pharmaceutical compounds
08/21/1996CN1129102A Catechol diether compounds as inhibitors of TNF release
08/20/1996US5547986 Ester of L-carnitine with gamma-hydroxybutyric acid and pharmaceutical compositions containing it for inhibiting neuronal degeneration and for the treatment of coma
08/20/1996US5547978 Derivatives of pyrrolidin-2-ylcarbonylheterocyclic compounds
08/20/1996US5547977 Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8(and 1,3A,8)-di (and Tri) methylpyrrolo (2,3-B) indoles
08/20/1996US5547965 Use of substituted amines for the treatment of brain function disorders
1 ... 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 ... 1833